ENCOURAGING RESPONSE OF AN ADVANCED STEROID-CELL TUMOR TO GNRH AGONIST THERAPY

    loading  Checking for direct PDF access through Ovid

Abstract

Background

Chemotherapy for steroid tumors of unspecified type has met with limited success and the overall prognosis has been poor.

Case

A patient with a virilizing steroid tumor, otherwise unspecified, with demonstrated progressive disease after surgical debulking. Treatment with multiagent chemotherapy failed, but the patient subsequently had a robust response to GnRH agonist therapy.

Conclusion

GnRH analogue treatment should be considered prior to cytotoxic chemotherapy in cases of steroid tumor, not otherwise specified.

Related Topics

    loading  Loading Related Articles